Nicotine Polacrilex Lozenge
Product Images NDC 43598-486

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nicotine Polacrilex (NDC 43598-486). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Nicotine Polacrilex Lozenge 2 mg packaging label from Dr. Reddy's Laboratories Inc. The label includes branding, dosage strength, product use as a stop smoking aid, and mint flavor designation. It states the package contains 24 lozenges, each 2 mg. The label features directions, drug facts, warnings, and instructions to increase success in quitting smoking.*

FDA Label Image

Carton2 (Carton2)

Nicotine Polacrilex Lozenge 4 mg packaging label by Dr. Reddy's Laboratories Inc. The label describes the product as a stop smoking aid with a mint flavor, containing 24 individual lozenges each with 4 mg of nicotine polacrilex. The packaging includes drug facts, usage instructions, warnings, inactive ingredients, and directions for use. It highlights the importance of using the product to increase quitting success and provides barcode and distributor information.*

FDA Label Image

Container1 (Container1)

Label for Nicotine Polacrilex Lozenge 2 mg by Dr. Reddy's Laboratories Inc. The label indicates it is a stop smoking aid with mint flavor. It shows a package count of 24 lozenges, each containing 2 mg of nicotine polacrilex. The label includes usage directions and warnings, plus identification information such as NDC 43598-486-24 and a lot/expiration section.*

FDA Label Image

Container2 (Container2)

Dr. Reddy's Nicotine Polacrilex Lozenge 4 mg label for a stop smoking aid. The mint-flavored lozenges come in a 24-count package with each lozenge containing 4 mg of nicotine polacrilex. The label includes dosing instructions by week, contamination warnings, and storage guidance. It specifies that the product is made in Denmark and distributed by Dr. Reddy's Laboratories Inc.*

FDA Label Image

Fig1 (Fig1)

An instructional diagram showing a schedule for nicotine polacrilex lozenge use over time. It advises Step 1 during week 1 to take 1 lozenge every 1 to 2 hours, Step 2 during week 7 to take 1 lozenge every 2 to 4 hours, and Step 3 during week 10 to take 1 lozenge every 4 to 8 hours. The diagram also marks the 'EX-SMOKER' status at 12 weeks after the quit date.*

FDA Label Image

Pic1 (Pic1)

A wallet card titled 'WHERE TO CALL FOR HELP' listing four support contacts: American Lung Association, American Cancer Society, American Heart Association, and an encouragement to contact a quitting buddy or friend who has quit, each with corresponding phone numbers for smoking cessation support.*

FDA Label Image

Pic2 (Pic2)

An illustrated wallet card titled 'My most important reasons to quit smoking are:' followed by several blank lines for personalized entries. The card provides a space to write motivational reasons to support smoking cessation efforts.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.